Literature DB >> 12217370

Sordarin oxazepine derivatives as potent antifungal agents.

Michael H Serrano-Wu1, Denis R St Laurent, Yijun Chen, Stella Huang, Kin-Ray Lam, James A Matson, Charles E Mazzucco, Terry M Stickle, Thomas P Tully, Henry S Wong, Dolatrai M Vyas, Balu N Balasubramanian.   

Abstract

The synthesis and biological activity of sordarin oxazepine derivatives are described. The key step features a regioselective oxidation of an unprotected triol followed by double reductive amination to afford the ring-closed products. The spectrum of antifungal activity for these novel derivatives includes coverage of Candida albicans, Candida glabrata, and Cryptococcus neoformans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217370     DOI: 10.1016/s0960-894x(02)00529-2

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Improvement of sordarin production through process optimization: combining traditional approaches with DOE.

Authors:  Thomas P Tully; James S Bergum; Steven R Schwarz; Susan C Durand; Jeffrey M Howell; Ramesh N Patel; Paul M Cino
Journal:  J Ind Microbiol Biotechnol       Date:  2006-11-28       Impact factor: 3.346

2.  Michael Reaction of 3-aAryl-2,4-Dicarboethoxy-5-Hydroxy-5-Methylcyclohexanones.

Authors:  Fawzia Zakaria El-Ablack; M A Metwally; A M Khalil
Journal:  Org Chem Int       Date:  2015-09-01

3.  Synthesis of chiral 1,4-oxazepane-5-carboxylic acids from polymer-supported homoserine.

Authors:  Petra Králová; Barbora Lemrová; Michal Maloň; Miroslav Soural
Journal:  RSC Adv       Date:  2020-09-30       Impact factor: 4.036

4.  Sordarin, an antifungal agent with a unique mode of action.

Authors:  Huan Liang
Journal:  Beilstein J Org Chem       Date:  2008-09-05       Impact factor: 2.883

5.  A One-Pot Synthesis of Oxazepine-Quinazolinone bis-Heterocyclic Scaffolds via Isocyanide-Based Three-Component Reactions.

Authors:  Shabnam Shaabani; Ahmad Shaabani; Monika Kucerakova; Michal Dusek
Journal:  Front Chem       Date:  2019-09-18       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.